Pratishtha Singh

1.3k total citations · 2 hit papers
12 papers, 793 citations indexed

About

Pratishtha Singh is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Pratishtha Singh has authored 12 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Physiology and 2 papers in Oncology. Recurrent topics in Pratishtha Singh's work include Protein Structure and Dynamics (2 papers), Pain Mechanisms and Treatments (2 papers) and Biochemical effects in animals (2 papers). Pratishtha Singh is often cited by papers focused on Protein Structure and Dynamics (2 papers), Pain Mechanisms and Treatments (2 papers) and Biochemical effects in animals (2 papers). Pratishtha Singh collaborates with scholars based in United States, India and Canada. Pratishtha Singh's co-authors include Deblina Raychaudhuri, Sangeeta Goswami, Swetha Anandhan, Candice C. Poon, Padmanee Sharma, Shajedul Islam, James P. Allison, Jielin Liu, Gayathri Anandappa and Moran Amit and has published in prestigious journals such as Cell, Nature Communications and Nature Immunology.

In The Last Decade

Pratishtha Singh

10 papers receiving 781 citations

Hit Papers

Immune checkpoint therapy—current perspectives and future... 2023 2026 2024 2025 2023 2024 100 200 300 400 500

Peers

Pratishtha Singh
Haiyan Xu China
Yajie Yin United States
Qiongyu Hao United States
Pratishtha Singh
Citations per year, relative to Pratishtha Singh Pratishtha Singh (= 1×) peers Kosuke Kawaguchi

Countries citing papers authored by Pratishtha Singh

Since Specialization
Citations

This map shows the geographic impact of Pratishtha Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pratishtha Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pratishtha Singh more than expected).

Fields of papers citing papers by Pratishtha Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pratishtha Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pratishtha Singh. The network helps show where Pratishtha Singh may publish in the future.

Co-authorship network of co-authors of Pratishtha Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Pratishtha Singh. A scholar is included among the top collaborators of Pratishtha Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pratishtha Singh. Pratishtha Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Singh, Pratishtha, Ranit D’Rozario, Deblina Raychaudhuri, et al.. (2026). Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancer. Nature Communications. 17(1). 1382–1382.
3.
Poon, Candice C., Shelley M. Herbrich, Yulong Chen, et al.. (2025). Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome. Cancer Immunology Research. 13(6). 804–820. 2 indexed citations
4.
Raychaudhuri, Deblina, et al.. (2024). Histone lactylation drives CD8+ T cell metabolism and function. Nature Immunology. 25(11). 2140–2151. 74 indexed citations breakdown →
5.
Goswami, Sangeeta, Deblina Raychaudhuri, Pratishtha Singh, et al.. (2023). Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade. Nature Cancer. 4(10). 1455–1473. 27 indexed citations
6.
Sharma, Padmanee, Sangeeta Goswami, Deblina Raychaudhuri, et al.. (2023). Immune checkpoint therapy—current perspectives and future directions. Cell. 186(8). 1652–1669. 579 indexed citations breakdown →
7.
8.
Singh, Pratishtha, Seema Bansal, Anurag Kuhad, Anil Kumar, & Kanwaljit Chopra. (2020). Naringenin ameliorates diabetic neuropathic pain by modulation of oxidative-nitrosative stress, cytokines and MMP-9 levels. Food & Function. 11(5). 4548–4560. 45 indexed citations
9.
Singh, Pratishtha, et al.. (2019). Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b). Journal of Chemical Information and Modeling. 59(12). 5294–5303. 3 indexed citations
10.
Singh, Pratishtha, et al.. (2017). In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b) – CB1 cannabinoid receptor. Journal of Molecular Graphics and Modelling. 77. 311–321. 7 indexed citations
11.
Kuhad, Anurag, Pratishtha Singh, & Kanwaljit Chopra. (2014). Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain. Expert Opinion on Therapeutic Targets. 19(2). 177–185. 36 indexed citations
12.
Singh, Pratishtha & Raju Prasad Sharma. (1994). Effect of orpiment (As2S3) on cytochrome P-450, glutathione and lipid peroxide levels of rat liver.. PubMed. 13(3). 199–203. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026